Keep up to date with the latest news from Accelagen
Accelagen Staff Announcement: Amritha Vangur
Today we are thrilled to announce that Amritha Vangur has rejoined our team as Clinical Research Associate.
Accelagen Staff Announcement: Suzanne Leong and Victor Patino
We are excited to formally welcome another two highly experienced team members to our team, Suzanne Leong and Victor Patino.
Accelagen Staff Announcement: Sian Gilmour
Today we are excited to share that we have appointed an exciting emerging talent in Clinical Research Associate, Sian Gilmour.
Accelagen introduces SureClinical Tools to aid in Clinical Trial Management
Accelagen has partnered with SureClinical to gain access to their range of electronic trial management tools, commencing with the SureClinical eTMF.
Accelagen facilitates LEDAGA Approval in Australia
We're pleased to be an integral part of the approval of LEDAGA® by TGA on behalf of the Australian office of Recordati Rare Diseases.
Accelagen driving development of new candidate for COVID-19 Vaccine
Accelagen is excited to announce the initiation of a new COVID-19 vaccine trial, commencing in Melbourne on Tuesday 1st September!
Conformity Assessment Application
We've successfully assisted an Australian manufacturer lodge their first CAA.
Accelagen Staff Announcement: Johan van Wyk
We're delighted to welcome Johan van Wyk as General Manager, Biometrics and Partner Engagement in our rapidly growing team.
Accelagen Staff Announcement: Kylie Lord
Accelagen is thrilled to officially welcome Kylie Lord as our company’s first CFO.